ANKRD40CL

Across TCGA pan-cancer cohorts, ANKRD40CL RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated ANKRD40CL data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ANKRD40CL RNA is associated with better overall survival. In most high-consensus cancer types, elevated ANKRD40CL expression acts as an unfavorable survival marker, although some lineages such as BLCA and THCA show a favorable association.

BLCA, UCEC, and ESCA are the cancer types where ANKRD40CL RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.695	0.551	.001	59	view →
UCEC	DFS	Quartile	All	0.874	0.923	.004	56	view →
ESCA	OS	Tertile	All	0.456	1.000	.008	24	view →
OV	DFS	Median	II,III,IV	0.494	0.575	.018	16	view →
PRAD	DFS	Tertile	All	0.738	0.903	.001	16	view →
STAD	DFS	Tertile	IV	0.254	0.805	.049	12	view →
COAD	OS	Tertile	III,IV	0.493	0.811	.006	11	view →
KICH	OS	Quartile	All	0.657	0.950	.006	9	view →
CHOL	OS	Median	IV	0.208	0.948	.010	9	view →
PCPG	DFS	Tertile	All	0.832	0.945	.016	9	view →
LUAD	OS	Quartile	III,IV	0.337	0.546	.038	5	view →
KIRP	DFS	Quartile	All	0.510	0.831	.010	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

ANKRD40CL–BLCA (OS)

Open the BLCA breakdown →